Management Board section is now available on Farmak’s website

As of 27 March 2024, Farmak’s International Office has successfully finalized its acquisition of Symphar, becoming the sole owner of the Polish pharmaceutical company. The acquisition represents a part of Farmak’s international expansion strategy “Farmak 2.0: From local to global success”. This M&A is an important next step after last year’s ...

At the beginning of March, the European Congress of Radiology (ECR) was held in Vienna, Austria. The leader of the Ukrainian pharmaceutical market*, Farmak presented at ECR contrast drugs used during magnetic resonance imaging. ECR is one of the largest medical events in Europe and the second largest radiology conference in the world. More than […]

The pharmaceutical company Farmak took part in a two-day blood donation marathon organized by the Ministry of Justice of Ukraine. In total, the campaign managed to collect more than 315 liters of blood, more than 10 of which were donated by Farmak employees. The blood donation marathon was held jointly with the Kyiv Central Interregional […]